Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence.

× No keyword cloud information.

15 in total

1. Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.

Authors: F Cerrato; M E Fernández-Suárez; R Alonso; M Alonso; C Vázquez; O Pastor; P Mata; M A Lasunción; D Gómez-Coronado
Journal: Br J Pharmacol Date: 2015-01-08 Impact factor: 8.739

Review 2. The potential role of Kv4.3 K+ channel in heart hypertrophy.

Authors: Rong Huo; Yue Sheng; Wen-Ting Guo; De-Li Dong
Journal: Channels (Austin) Date: 2014 Impact factor: 2.581

Review 3. Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Authors: F Khosrow-Khavar; K B Filion; S Al-Qurashi; N Torabi; N Bouganim; S Suissa; L Azoulay
Journal: Ann Oncol Date: 2017-03-01 Impact factor: 32.976

4. Comparison of dyslipidemia incidence in Chinese early-stage breast cancer patients following different endocrine therapies: A population-based cohort study.

Authors: Junren Wang; Jin Yin; Jiajun Qiu; Jingwen Jiang; Yao Hu; Kunrui Zhu; Hong Zheng; Ting Luo; Xiaorong Zhong
Journal: Front Endocrinol (Lausanne) Date: 2022-09-06 Impact factor: 6.055

Review 5. The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review.

Authors: Torbjørn Omland; Siri Lagethon Heck; Geeta Gulati
Journal: JACC CardioOncol Date: 2022-03-15

6. Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control study.

Authors: E F H van Bommel; L J H van Tits; E A van den Berg; J Prins; A F H Stalenhoef
Journal: Rheumatol Int Date: 2009-12-12 Impact factor: 2.631

Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence.

1. Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.

Review 2. The potential role of Kv4.3 K+ channel in heart hypertrophy.

Review 3. Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.

4. Comparison of dyslipidemia incidence in Chinese early-stage breast cancer patients following different endocrine therapies: A population-based cohort study.

Review 5. The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review.

6. Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control study.

7. Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy.

8. Cardiotoxicity of Use of Sequential Aromatase Inhibitors in Women With Breast Cancer.

9. Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy.

10. Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level.